{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:47:35Z","timestamp":1740174455973,"version":"3.37.3"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022955","name":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.gore.2024.101544","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T23:41:58Z","timestamp":1731109318000},"page":"101544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vulvar squamous cell carcinoma: The role of p53 and p16 immunohistochemistry"],"prefix":"10.1016","volume":"56","author":[{"given":"Helena M","family":"Obermair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Elhindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unine","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gore.2024.101544_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ygyno.2011.05.016","article-title":"Does human papillomavirus infection imply A different prognosis in vulvar squamous cell carcinoma?","volume":"122","author":"Alonso","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2024.101544_b0010","doi-asserted-by":"crossref","first-page":"3739075","DOI":"10.1155\/2020\/3739075","article-title":"The clinical relevance of p16 and p53 status in patients with squamous cell carcinoma of the vulva","volume":"2020","author":"Barlow","year":"2020","journal-title":"J. Oncol."},{"key":"10.1016\/j.gore.2024.101544_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-003616","article-title":"HPV-independent and HPV-associated vulvar squamous cell carcinoma: Two different cancers","author":"Eva","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"10.1016\/j.gore.2024.101544_b0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/a-1545-4279","article-title":"2020 WHO classification of female genital tumors","volume":"81","author":"H\u00f6hn","year":"2021","journal-title":"Geburtshilfe. Frauenheilkd."},{"key":"10.1016\/j.gore.2024.101544_b0025","unstructured":"McAlpine, J.,2024. STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision (STRIVE) ClinicalTrials.gov: ClinicalTrials.gov; [updated 19\/08\/2024; cited 2024 September 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05576831."},{"issue":"1","key":"10.1016\/j.gore.2024.101544_b0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/ijgc-2019-000793","article-title":"Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma","volume":"30","author":"Proctor","year":"2020","journal-title":"Int. J Gynecol. Cancer."},{"issue":"1","key":"10.1016\/j.gore.2024.101544_b0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2018.10.015","article-title":"The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis","volume":"152","author":"Sand","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2024.101544_b0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/IGC.0b013e318241d994","article-title":"Validation of the FIGO 2009 staging system for carcinoma of the vulva","volume":"22","author":"Tan","year":"2012","journal-title":"Int. J. Gynecol. Cancer."},{"issue":"8","key":"10.1016\/j.gore.2024.101544_b0045","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod. Pathol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924002236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924002236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:03:46Z","timestamp":1734048226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578924002236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":9,"alternative-id":["S2352578924002236"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2024.101544","relation":{},"ISSN":["2352-5789"],"issn-type":[{"type":"print","value":"2352-5789"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vulvar squamous cell carcinoma: The role of p53 and p16 immunohistochemistry","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2024.101544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101544"}}